Emmaus Life Sciences's market cap is currently $766.39K. The company's EPS TTM is $-0.018; its P/E ratio is ―; Emmaus Life Sciences is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
